Search for: "Merck & Company, Inc."
Results 61 - 80
of 445
Sort by Relevance
|
Sort by Date
22 Mar 2018, 1:23 pm
Shortly thereafter Schering-Plough Corporation merged with Merck & Company, Inc., who kept Solis on in his same role for a year before firing him. [read post]
20 Mar 2018, 7:27 am
Millennium Pharmaceuticals, Inc., March 15, 2018, Wallace, W.). [read post]
17 Mar 2018, 7:18 am
” Nate Raymond of Reuters has a report that begins, “Massachusetts’ top court on Friday opened the door for consumers to sue Merck & Co Inc and other makers of brand-name drugs over injuries blamed not on their own medications but on generic versions of their treatments made by other companies. [read post]
14 Feb 2018, 2:57 pm
ANZ Securities, Inc. [read post]
29 Jan 2018, 2:57 am
The French government (represented by the public ‘Atout France’ and the French Ministry of Culture) disputed the registration by a private US company, France.com Inc, of a series of trade marks using the word “France.com”. [read post]
1 Dec 2017, 11:35 am
Merck & Co is currently ranked No.1 in R&D, although it is fourth in sales. [read post]
15 Nov 2017, 12:34 pm
Merck & Co. v. [read post]
17 Oct 2017, 6:09 pm
Judge Robinson had concluded that the patent was valid, and applied the test articulated in eBay Inc. v. [read post]
18 Sep 2017, 11:12 am
Its ruling is the latest in a series of plaintiff-friendly decisions that misconstrued the Supreme Court’s landmark 2009 ruling in Wyeth Inc. v. [read post]
24 Jun 2017, 9:12 pm
Paul Jahn of Morrison & Foerster LLP; William Krovatin of Merck & Co., Inc.; and Richard Rainey of Covington & Burling LLP will explore the significant ramifications of the recent U.S. [read post]
16 Jun 2017, 9:44 am
This year's winners and technologies are: Merck & Co., Inc. in Greener Synthetic Pathways -- Letermovir: A Case Study in State-of-the-Art Approaches to Sustainable Commercial Manufacturing Processes in the Pharmaceutical Industry; Amgen Inc. and Bachem in Greener Reaction Conditions -- Green Process for Commercial Manufacture of Etelcalcetide Enabled by Improved Technology for Solid Phase Peptide Synthesis; The Dow Chemical… [read post]
12 Jun 2017, 3:18 pm
This year's winners and technologies are: Merck & Co., Inc. in Greener Synthetic Pathways - Letermovir: A Case Study in State-of-the-Art Approaches to Sustainable Commercial Manufacturing Processes in the Pharmaceutical Industry Merck’s approach was to design an efficient synthesis as early as possible in the drug Letermovir’s process development. [read post]
6 Apr 2017, 1:35 pm
The initial text of the decision in The Medicines Company v. [read post]
3 Mar 2017, 7:25 am
Inc. [2007] EWHC 1900 (Pat) and that describing these declarat [read post]
8 Feb 2017, 3:09 am
Shell Oil Company, et al., No. 16-713 BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
16 Jan 2017, 5:44 pm
Shell Oil Company, et al., No. 16-713 BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
30 Dec 2016, 2:58 pm
The case deals with whether an English letter sent by a German company to a US company based on EU trademark infringement constitutes a groundless threat under the Trade Marks Act 1994.PREVIOUSLY ON NEVER TOO LATENever Too Late 127 [week ending on Sunday 18 December] | Around the IP Blogs | Top-level Property Rights Protection Guideline released in China | CEIPI/EAO Conference--"Copyright Enforcement in the Online World" | More on the Swedish application of GS Media |… [read post]
14 Nov 2016, 9:16 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
31 Oct 2016, 6:09 am
OrthoAccel Technologies, Inc. v. [read post]
13 Oct 2016, 6:50 am
Post Grant Admin: Merck & Cie, et al. v. [read post]
